Skip to main content
Premium Trial:

Request an Annual Quote

BioMerieux, Knome Team on Sequencing-Based MDx

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioMérieux and Knome announced today that they will collaborate on developing next-generation sequencing-based molecular diagnostics.

The collaboration includes the French diagnostics firm taking a $5 million equity stake in Knome. Though the firms did not disclose the details of the investment or further financial terms, they said that BioMérieux has the right to designate one director for election to the board of directors of privately held Knome.

Under terms of the agreement, BioMérieux will have exclusive rights to license Knome's genome analysis platform for use in the in vitro diagnostics market. In return, Knome gains access to BioMérieux's intellectual property in DNA extraction and sample preparation.

BioMérieux said that developing multiplex, DNA sequencing-based diagnostics is part of its 2015 strategic roadmap. The firm said that it intends to develop next-generation cancer and infectious disease diagnostics using Knome's sequence analysis technology and bioinformatic tools.

Cambridge, Mass.-based Knome, which launched in late 2007 as a personal genomics firm, last year inked a deal with SeqWright, under which Knome's personal genome sequencing and analysis service is offered through SeqWright's CLIA-certified laboratory.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.